Literature DB >> 1778886

Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host.

D W Denning1.   

Abstract

The epidemiology and pathogenesis of invasive candidosis and aspergillosis, cryptococcal meningitis, mucormycosis and disseminated histoplasmosis are reviewed. Particular areas of growth of knowledge that are emphasized are the epidemiology of candidosis and aspergillosis, putative virulence factors in aspergillosis and the pathogenesis of cryptococcosis.

Entities:  

Mesh：

Year:  1991        PMID： 1778886     DOI： 10.1093/jac/28.suppl_b.1

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  22 in total

Review 1.  Antifungal agents: chemotherapeutic targets and immunologic strategies.

Authors:  N H Georgopapadakou; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

Review 2.  Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.

Authors:  A J Coukell; R N Brogden
Journal:  Drugs       Date:  1998-04       Impact factor: 9.546

3.  Amphotericin B prophylaxis against invasive fungal infections in neutropenic patients: a single center experience from 1980 to 1995.

Authors:  A De Laurenzi; A Matteocci; A Lanti; L Pescador; F Blandino; C Papetti
Journal:  Infection       Date:  1996 Sep-Oct       Impact factor: 3.553

4.  Differential antifungal activity of isomeric forms of nystatin.

Authors:  L Ostrosky-Zeichner; S Bazemore; V L Paetznick; J R Rodriguez; E Chen; T Wallace; P Cossum; J H Rex
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

Review 5.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 6.  Lipid formulations of amphotericin B. Less toxicity but at what economic cost?

Authors:  J Tollemar; O Ringdén
Journal:  Drug Saf       Date:  1995-10       Impact factor: 5.606

7.  Aspergillus antigenuria compared to antigenemia in bone marrow transplant recipients.

Authors:  R Ansorg; E Heintschel von Heinegg; P M Rath
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

8.  Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions.

Authors:  Susanne Perkhofer; Daniel Jost; Manfred P Dierich; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

9.  Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party.

Authors: 
Journal:  Intensive Care Med       Date:  1994-08       Impact factor: 17.440

10.  Aspergillus fumigatus-induced interleukin-8 synthesis by respiratory epithelial cells is controlled by the phosphatidylinositol 3-kinase, p38 MAPK, and ERK1/2 pathways and not by the toll-like receptor-MyD88 pathway.

Authors:  Viviane Balloy; Jean-Michel Sallenave; Yongzheng Wu; Lhousseine Touqui; Jean-Paul Latgé; Mustapha Si-Tahar; Michel Chignard
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.